✦ LIBER ✦

Phase II study of sequential docetaxel (Taxotere®, TXT) and doxorubicin (Dox) as primary chemotherapy (CT) for large operable breast cancer (BC)

✍ Scribed by V. Laurence; V. Girre; J.M. Extra; V. Dieras; T. Palangie; J. Dorval; J.Y. Pierga; M. Jouve; P. Beuzeboc; P. Pouillart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary data of a phase II randomize

✍ Koroleva, I.; Wojtukiewicz, M.; Zaluski, J.; Korytova, L.; Biakhov, M.; Gadel-Ma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Phase II study of dose-dense sequential

✍ Brenda W. Cooper; Tomas Radivoyevitch; Beth A. Overmoyer; Robert R. Shenk; Huong 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 208 KB

A Phase II Study of Sequential Docetaxel

✍ Antonio Antón; Javier Hornedo; Ana Lluch; Bartomeu Massuti; Mónica Corral; Ramon 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

A randomized phase II study of combinati

✍ Cresta, S. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 100 KB

Phase II study of dose-dense doxorubicin

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB

Phase II study of liposome-encapsulated

✍ Saracchini, S.; Foltran, L.; Tuccia, F.; Bassini, A.; Sulfaro, S.; Micheli, E.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 548 KB